Objective To evaluate the relationships of depression and anxiety symptoms with cardiovascular disease (CVD) risk factors and measures of vascular health in youth.
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ORIGINAL ARTICLES
Existing evidence suggests that the relationship between mental health and CVD risk is strongest among individuals who meet diagnostic criteria for a major depressive disorder and bipolar disorder. 2 It is less clear, however, if other forms of depression or other mental health conditions are associated with heightened CVD risk in children and adolescents. The purpose of the current study was to evaluate the relationship between self-reported depression and anxiety symptoms and CVD risk factors, cardiac autonomic function, and vascular structure and function in children and adolescents representing a wide range of ages, pubertal maturations, and obesity statuses.
Methods
Participants included in this analysis were children and adolescents 8-18 years of age who had normal weight, overweight/ obesity, or severe obesity. They were part of a larger crosssectional study evaluating endothelial health. Participants were recruited from general pediatric clinics at the University of Minnesota, the University of Minnesota Pediatric Weight Management Clinic, and the broader community. Exclusion criteria were obesity from a known genetic cause, history of bariatric surgery, illness or significant injury in previous 2 weeks, type 1 diabetes mellitus, familial hypercholesterolemia, chronic kidney disease/end-stage renal disease, Kawasaki disease, autoimmune inflammatory diseases, congenital heart disease, or recent (within 3 months) use of medications known to affect endothelial health such as statins, angiotensin-converting enzyme inhibitors, peroxisome proliferator activated receptorgamma agonists, or third-generation beta-blockers. All parents/ legal guardians and participants provided informed consent and assent, respectively. The University of Minnesota Institutional Review Board approved the protocol and study procedures.
All testing was performed in the morning after the participants had been fasting (including no caffeine consumption) for a minimum of 12 hours. Height and weight were determined using a wall-mounted stadiometer and an electronic scale, respectively. Body mass index (BMI) was calculated as the body weight in kilograms divided by the height in meters squared. BMI percentiles were determined using age-and sexbased definitions from the Centers for Disease Control and Prevention. Normal weight was defined as ≥5th to <85th percentile, overweight/obesity was defined as ≥85th to <120% of the 95th percentile, and severe obesity was defined as ≥120% of the 95th percentile or an absolute BMI of ≥35 kg/m 2 . 9 Total and regional body composition was measured using dual x-ray absorptiometry (GE Healthcare Lunar, Madison, Wisconsin) and analyzed using enCore software (platform version 16.2, GE Healthcare). Participants were scanned using standard imaging and positioning protocols while fasting. Tanner stage was determined by a trained pediatrician or registered nurse. Seated blood pressure and heart rate were measured after the participant had been resting quietly without legs crossed for 10 minutes. Three consecutive measurements were taken with an automated brachial cuff at approximately 3-minute intervals and the average of the 3 measurements was used for analysis. Lipid, glucose, and insulin values were determined with standard methods by the University of Minnesota, Fairview Diagnostic Laboratory.
The SphygmoCor MM3 system (AtCor Medical, Sydney, Australia) was used to measure supine heart rate variability after participants had been at rest for approximately 10 minutes. The electrocardiogram signal was continuously recorded throughout the 15-minute data collection period. Only data collected during the last 5 minutes were used for analysis, and this segment was reviewed for ectopic heartbeats or arrhythmias. Any portions of the selected segment with abnormal electrocardiogram signals were excluded from analysis. Automated algorithms were used to calculate the SD of the RR interval, low frequency, high frequency, and the low frequency to high frequency ratio, all of which are metrics of the overall sympathovagal balance of the autonomic nervous system. Low values of the SD of the RR interval and high values of low frequency to high frequency ratio are suggestive of a state of elevated sympathetic tone and/or reduced parasympathetic tone.
All vascular testing was performed in the Vascular Biology Laboratory in the University of Minnesota Clinical and Translational Science Institute in a quiet, temperature-controlled environment (22°C-23°C). Artery images were measured by a noninvasive ultrasound examination with participants in the supine position. All images were digitized and stored on a personal computer for later off-line analysis of carotid artery intima-media thickness, compliance and distensibility, as well as brachial artery flow-mediated dilation (FMD). Electronic wall-tracking software was used for the analysis (Vascular Research Tools 5, Medical Imaging Application, LLC, Iowa City, Iowa).
After 15 minutes of quiet rest in the supine position, vascular images were obtained of the carotid artery using a conventional ultrasound scanner (Acuson, Sequoia 512, Siemens Medical Solutions USA, Inc, Mountain View, California) with a 15-8 MHz linear array probe held at a constant distance from the skin and at a fixed point over the imaged artery. The transducer was held at a constant distance from the skin and at a fixed point over the common carotid artery, approximately 1 cm proximal from the carotid bifurcation bulb, to capture the left common carotid artery's lumen diastolic and systolic diameters and carotid artery intima-media thickness. Depth and gain settings were set to optimize images of the lumen/ arterial wall interface. Systolic and diastolic blood pressures were recorded with an automated blood pressure device during the 10-second carotid measurements. The ultrasound scanning system was interfaced with a standard personal computer equipped with a data acquisition card for the attainment of radiofrequency ultrasound signals from the scanner. Images were collected at 20 frames per second for 10 seconds (200 frames) to ensure the capture of full arterial diameter change during a cardiac cycle. Carotid elasticity properties were calculated using previously published formulas. 10 Endothelial function was expressed by brachial artery FMD. FMD was measured via standard ultrasound using a 8-15 MHz linear array transducer to obtain B-mode images (Siemens, Sequoia 512, New York, New York) following current guidelines. 11 An electronic wall tracking software program (Medical Imaging Applications, Coralville, Iowa) was used for the measurement of brachial artery diameter and blood flow. After obtaining baseline measurements, a blood pressure cuff was placed on the forearm (distal to the imaged area) and inflated to a suprasystolic level (>200 mm Hg) for 5 minutes. After 5 minutes, cuff occlusion was released and B-mode ultrasound images were captured for approximately 3 minutes after release. The maximum diameter recorded following reactive hyperemia was reported relative to baseline vessel diameter (FMD% = [peak diameter -baseline diameter]/ baseline diameter). The same group of ultrasonographers conducted the measurements under the supervision of the same laboratory director throughout. Our laboratory has previously documented satisfactory FMD reproducibility. 12 Carotid-radial artery pulse wave velocity (PWV) was measured by the SphygmoCor MM3 system. PWV was calculated as distance divided by transit time. Pulse wave transit time increases in stiffer arterial segments; therefore, higher values of PWV represent increased arterial stiffness.
A metabolic syndrome cluster score was calculated as previously reported. 13 The score was determined by using the average of standardized deviates of the primary components of the metabolic syndrome (ie, the sum of the 5 sample z-scores of waist circumference, triglycerides, inverse high-density lipoprotein cholesterol, mean arterial pressure, and homeostasis model of insulin resistance divided by 5).
14 A higher sample z-score indicates that the components tend to cluster in the higher sections of the sampling distributions, that is, it represent overall higher risk among the study participants included here.
Anxiety was assessed using the Screen for Child Anxiety Related Disorders (SCARED). The SCARED is a 41-item selfreport measure of anxiety symptoms experienced in the prior 3 months, wherein items are answered using a 3-point Likerttype scale. 15 Scores range from 0 to 82 and, according to the SCARED, a score of 25 or greater is suggestive of anxiety. Missing responses were imputed for those missing 4 or fewer responses by question subgroup using the mean in the subgroup of the nonmissing responses. For those missing more than 4 responses, anxiety was left as missing.
Depression was assessed using the Center for Epidemiological Studies Depression Scale for Children (CES-DC). The CES-DC is a self-report measure including 20 items that participants rate on 4-point Likert-type scale regarding their symptoms for the prior week. 16 Scores range from 0 to 60. Based on the CES-DC, a score of 16 or greater is suggestive of depression. Missing responses were imputed for those missing fewer than 2 responses using the mean of their nonmissing responses. Responses were left as missing if 2 or more were missing.
Descriptive characteristics were calculated for the sample overall and separately for those with and without each of anxiety and depression using mean (SD) for continuous variables and n (%) for categorical variables. Two sets of adjustment variables were used to evaluate the mean differences between those with and without anxiety or depression for each of the cardiometabolic outcomes using generalized estimating equations. The first set (model 1) adjusted for Tanner stage, sex, and race (ie, white vs other); the second set (model 2) additionally adjusted for percent body fat. Although a measure of BMI has clinical usefulness, it is an estimate of body composition. Therefore, percent body fat was used as a covariate. Confidence intervals and P values were evaluated based on robust variance estimation. All statistical analyses were performed using R v3.3.1 (Foundation for Statistical Computing, Vienna, Austria). 17 
Results
There were 202 participants (52% male; mean age of 12.7 years) who had complete or imputed scores on SCARED or CES-DC ( Table I) . Approximately one-half of the sample was classified as having normal weight and almost one-third were in Tanner stage 1 pubertal development. The mean composite score for the 196 participants who had scores for SCARED was 16.5 (±13.0) and 50 of these participants (26%) scored at or above the threshold suggestive of anxiety. For the 201 participants who had scores for the CES-DC, the mean composite score was 11.2 (±8.6) and of these 47 (23%) scored at or above the threshold suggestive of depression. Additional information regarding participant demographics as well as cardiovascular and metabolic results are presented in Table I .
When controlling for Tanner stage, sex, and race, there were no significant relationships between anxiety symptomatology and the measures of CVD risk (P > .05; Table II) . In model 1, depression symptomatology was significantly associated with high-density lipoprotein cholesterol, triglycerides, and the metabolic syndrome cluster score; however, these findings were no longer significantly associated when additionally controlling for percent body fat in model 2 (Table III) . In fact, when controlling for percent body fat, almost no outcomes were significantly associated with anxiety or depression symptomatology (P > .05 [model 2]; Tables II and III), the only exception was anxiety symptomatology, which was associated with an increase in carotid artery cross-sectional compliance (P = .039 [model 2]; Table II) .
In addition to analyzing these results using a dichotomous cutoff for anxiety and depression symptomatology, the data were analyzed with depression and anxiety as continuous variables using the composite scores with imputation (tables not included). Findings were materially similar with one exception; carotid artery cross-sectional distensibility was higher with increased depressive symptoms when measured continuously. We also evaluated the data by separating younger and older participants (ie, ≥13 years of age vs <13 years of age). There were no appreciable differences in findings when analyzing the data by age groups (tables not included).
Discussion
In the current study, significant associations were observed between depression symptomatology and 2 components of the August 2018 ORIGINAL ARTICLES 
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Volume 199 metabolic syndrome score along with the score itself. However, these associations were not significant after controlling for body fat percentage. Further, no relationships were observed between anxiety symptomatology and CVD risk factors or vascular health. These findings suggests that, at least during childhood, the correlation between depression and anxiety symptomatology with CVD risk factors and vascular health may be emerging, but that excess adiposity may play a greater role in exacerbating risk.
Although the relationship between mental health and CVD risk in adulthood has been well-described, 18 less is known of these associations in children. Similar to adults, the association between severe mental health concerns (eg, diagnosed disorders, suicide attempts) and CVD events (eg, CVDrelated mortality) in youth is considered more established than milder forms of depression or anxiety and CVD risk. 2 Two population-based studies that included older adolescents and young adults, conducted in the United States and Taiwan found that diagnoses of depression, bipolar disorder, or anxiety were associated with increased CVD and CVD-related mortality. 19, 20 In a longitudinal study following participants from 9 to 21 years of age, depression diagnoses, depressive symptoms, and number of depressive episodes were associated with C-reactive protein levels; however, cumulative depressive episodes were most strongly related with elevated C-reactive protein levels even after controlling for other variables (eg, BMI, nicotine use). 21 In a BP, Blood pressure; cCSD, carotid artery cross-sectional distensibility; cCSC, carotid artery cross-sectional compliance; cIMT, carotid artery intima-media thickness; HDL, high-density lipoprotein; HF, high frequency; HR, heart rate; LDL, low-density lipoprotein; LF, low frequency; MetS, metabolic syndrome; VLDL, very low-density lipoprotein. *Model 1 (adjusted for Tanner grouping, sex, and race) and model 2 (adjusted for Tanner grouping, sex, race, and percent body fat) using robust variance estimation. longitudinal study of self-reported depressive symptoms and endothelial function in 15-to 19-year-old girls and women, current, but not prior, depressive symptoms predicted endothelial function (ie, pulse-wave amplitude). 22 In cross-sectional research with adolescents, depressive symptoms are associated with some, but not all, measures of cardiovascular health and/or endothelial function. 23, 24 Considering prior evidence, it is notable that the current study found associations between depression symptoms over the prior week (as asked on the CES-DC) and some CVD risk factors, even though these were nonsignificant after controlling for percent body fat.
Less is known about the relationship between anxiety and CVD risk in childhood. In children with anxiety disorders, a more severe anxiety symptom profile was associated with a greater number of CVD risk factors. 25 Interestingly, in a study using multiple measures of anxiety, increased anxiety symptoms reported on the Pediatric Anxiety Rating Scale was associated with greater waist circumference and percent body fat, yet anxiety symptoms as measured by SCARED were not associated with CVD risk factors. 25 Similarly, in the current study, SCARED results were not significantly associated with CVD risk factors or measures of vascular health.
Most prior studies either used measures of BMI or body fat as an outcome or controlled for these variables in statistical analyses. Those studies that have included BMI/body fat as an outcome often find a positive association with mental health symptoms; those that control for these variables often find that it at least attenuates relationships between mental health and other CVD risk factors. In the current study, controlling for percent body fat attenuated the relationships between depression symptomatology and components of the metabolic syndrome. Inconsistent with prior literature, the current results did not show any clear relationships after controlling for body fatness, even in areas where others had found associations (eg, depression and PWV). 23 One of the advantages of the current study was our ability to study a wide age range of children, including those as young as age 8. In contrast, prior research has often focused on adolescents up to young adults when considering the relationship between childhood mental health concerns and CVD risk. The relatively younger age group in the current study may help to explain our observations. That is, CVD development is likely occurring long before it can be observed in hard clinical or laboratory signs. 26 However, it should be noted that the results of our study were materially the same when younger children vs adolescents were analyzed separately.
Several strengths and limitations of this study are worth discussing. In addition to the wide age and BMI ranges, this was a well-characterized cohort of participants who underwent a comprehensive panel of cardiovascular measures. Although comprehensive, the current cardiovascular variables included clinical and laboratory measures of risk, rather than endstage CVD (eg, heart attack, stroke), which has been more clearly related to mental health concerns than earlier risk factors. Notably, it is quite uncommon for a child to reach the point of end-stage CVD and, therefore, it is not a practical measure to use for this population. Furthermore, the goal is to intervene before the point of end-stage disease. Another limitation of the study was our inability to measure additional variables that potentially contribute to the association between mental health and vascular health, for example, sleep, tobacco use, menstrual cycle, physical activity, diet, inflammation, and/ or oxidative stress. Given the array of factors measured in the current study, statistical analyses included multiple comparisons, which can increase the likelihood of a type I error. Although the cardiovascular panel was comprehensive, a limitation of the current study was the use of self-report questionnaires of depression and anxiety without a clinical interview or formal diagnosis. Consistent with prior research, symptomatology did not result in significant associations with CVD risk when controlling for percent body fat; these associations are more commonly found in the presence of a formal diagnosis of anxiety or depressive disorders. However, the use of self-report measures in research has practical implications given their clinical usefulness in gathering information regarding potential diagnoses and determining intervention strategies. In clinical practice, increases in such measures may warrant close monitoring, so that, if mental health concerns persist or escalate, both mental health interventions and preventive guidance related to CVD (eg, diet and physical activity recommendations) can be provided.
Our study was cross-sectional and did not include followup time-points. Furthermore, we observed associations between depression symptomatology and some CVD risk factors before controlling for percent body fat. Therefore, there is a possibility that those with increased mental health symptoms may eventually begin to demonstrate additional clinical or laboratory signs of CVD risk over time. Given the potential plasticity of the cardiovascular system during childhood, our results could be a reflection of physiologic compensation for increased stress from depression and/or anxiety symptomatology on the cardiovascular system. Because physiologic plasticity may decrease with age, childhood represents a potential window of opportunity for intervention to improve symptoms of depression and/or anxiety before vascular changes emerge and become resistant to change. Longitudinal studies are required to answer these important questions, because they would allow for the monitoring of disease progression as well as identify opportunities for intervention. ■
